Private Advisor Group, LLC Nymox Pharmaceutical Corp Transaction History

Private Advisor Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.95 - $2.1 $80,845 - $178,710	-85,100 Reduced 50.0%	85,100 $111,000
Q3 2021 Oct 14, 2021	BUY	$1.3 - $2.23 $180,830 - $310,193	139,100 Added 447.27%	170,200 $350,000
Q1 2020 May 12, 2020	SELL	$1.69 - $3.88 $11,238 - $25,802	-6,650 Reduced 17.62%	31,100 $73,000
Q2 2019 Aug 14, 2019	BUY	$1.33 - $2.12 $50,207 - $80,030	37,750 New	37,750 $55,000
Q1 2019 May 13, 2019	SELL	$1.57 - $2.71 $59,267 - $102,302	-37,750 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$1.31 - $2.53 $49,452 - $95,507	37,750 New	37,750 $49,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.